14 results found.

Dyskeratosis Congenita, or Aplastic Anemia Clinical Trial using Campath 1H; Cyclophosphamide; Fludarabine; Total Body Irradiation; Stem Cell Transplantation; antithymocyte globulin; Methylprednisolone

Masonic Cancer Center, University of Minnesota - Recruiting N/A to 70 years.
- Hematopoietic Stem Cell Transplant For Patients With Dyskeratosis Congenita and Severe Aplastic Anemia.
Campath 1H; Cyclophosphamide; Fludarabine; Total Body Irradiation; Stem Cell Transplantation; antithymocyte globulin; Methylprednisolone

Transfusional Iron Overload, Thalassemia Major, Sickle Cell Disea Clinical Trial using Hepatic biomagnetic susceptibility measurement

Columbia University - Recruiting 5 years to 80 years.
- High-Tc Susceptometer to Monitor Transfusional Iron Overload (NSR Device).
Hepatic biomagnetic susceptibility measurement

Aplastic Anemia, Neutropenia, Pancytopenia, Anemia, or Thrombocyt Clinical Trial using Eltrombopag; Horse Anti-Thymocyte Globulin (ATG); Cyclosporine A (CSA)

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Eltrombopag Added to Standard Immunosuppression in Treatment-Naive Severe Aplastic Anemia.
Eltrombopag; Horse Anti-Thymocyte Globulin (ATG); Cyclosporine A (CSA)

Myelodysplastic Syndrome (MDS), Hematologic Neoplasms, Hematologi Clinical Trial using Cord Blood Transplant

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications.
Cord Blood Transplant

Aplastic Anemia, Leukemia, Myelodysplastic Syndrome (MDS), or Lym Clinical Trial using Cord Blood Units

National Institutes of Health Clinical Center (CC) - Recruiting N/A or older.
- A Multicenter Safety Study of Unlicensed, Investigational Cryopreserved Cord Blood Units (CBUs) Manufactured by the National Cord Blood Program (NCBP) and Provided for Unrelated Hematopoietic Stem Cell Transplantation of Pediatric and Adult Patients.
Cord Blood Units

Severe Aplastic Anemia (SAA) Clinical Trial using Eltrombopag (promacta)

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Extended Dosing With Eltrombopag in Refractory Severe Aplastic Anemia.
Eltrombopag (promacta)

Aplastic Anemia, Bone Marrow Failure Syndromes, Idiopathic Pulmon Clinical Trial using Nandrolone Decanoate

University of Sao Paulo - Recruiting 2 years or older.
- Male Hormones for Telomere Related Diseases.
Nandrolone Decanoate

Relapsed or Refractory Severe Aplastic Anemia, or Severe Aplastic Clinical Trial using Alemtuzumab (Campath )

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- A Pilot Study of Alemtuzumab (Campath) in Patients With Relapsed or Refractory Severe Aplastic Anemia.
Alemtuzumab (Campath )

Aplastic Anemia Clinical Trial using Danazol

National Institutes of Health Clinical Center (CC) - Recruiting 2 years or older.
- Male Hormones for Telomere Related Diseases.
Danazol

Anemia, Aplastic, or Anemia, Hypoplastic Clinical Trial using h-ATG (ATGAM ); Cyclosporine (Gengraf )

National Institutes of Health Clinical Center (CC) - Recruiting 2 years to 82 years.
- Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment.
h-ATG (ATGAM ); Cyclosporine (Gengraf )

Aplastic Anemia Clinical Trial using ATG-fresenius

National Institute of Blood Disease Center, Pakistan - Recruiting 2 years to 65 years.
- Protocol for Comparison of Two Different Regimens of Rabbit ATG-Fresenius With Cyclosporin in the Treatment of Acquired Aplastic Anaemia.
ATG-fresenius

Aplastic Anemia, Leukemia, or Myelodysplastic Syndrome Clinical Trial using Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.; CliniMACS device

Memorial Sloan-Kettering Cancer Center - Recruiting N/A or older.
- A Multicenter Phase II Trial of Hematopoietic Stem Cell Transplantation for the Treatment of Patients With Fanconi Anemia Lacking a Genotypically Identical Donor, Using a Chemotherapy Only Cytoreduction With Busulfan, Cyclophosphamide and Fludarabine.
Busulfan, fludarabine, & cyclophosphamide with immunosuppression with ATG and cyclosporine.; CliniMACS device

Myelodysplastic Syndrome (MDS), or Severe Aplastic Anemia (SAA) Clinical Trial using Umbilical Cord Blood; Haploidentical Stem Cells; Miltenvi CliniMACs CD34 Reagent System

National Institutes of Health Clinical Center (CC) - Recruiting 4 years to 75 years.
- Co-Infusion of Umbilical Cord Blood and Haploidentical CD34+ Cells Following Nonmyeloablative Conditioning as Treatment for Severe Aplastic Anemia and MDS Associated With Severe Neutropenia Refractory to Immunosuppressive Therapy.
Umbilical Cord Blood; Haploidentical Stem Cells; Miltenvi CliniMACs CD34 Reagent System

Anemia, Aplastic Clinical Trial using Ex Vivo Immunotherapy; Ex vivo immunotherapy

Shenzhen Zhongxing Yangfan Biotech Co. Ltd. - Recruiting 10 years to 80 years.
- Phase I/II Study of An Ex Vivo Immunotherapy for Treatment of Idiopathic Aplastic Anemia.
Ex Vivo Immunotherapy; Ex vivo immunotherapy